Lineage Cell Therapeutics, Inc. Amortization of Deferred Charges
Lineage Cell Therapeutics, Inc. (LCTX) reported Amortization of Deferred Charges of $166.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredCharges · last filed 2018-11-08
- Lineage Cell Therapeutics, Inc. amortization of deferred charges for the quarter ending 2015-03-31 was $0.00.
- Lineage Cell Therapeutics, Inc. amortization of deferred charges for the quarter ending 2014-12-31 was -$720.00.
- Lineage Cell Therapeutics, Inc. amortization of deferred charges for the quarter ending 2014-09-30 was $0.00.
- Lineage Cell Therapeutics, Inc. amortization of deferred charges for the quarter ending 2014-06-30 was $0.00.
- Lineage Cell Therapeutics, Inc. amortization of deferred charges for fiscal 2015 was $102.00K.
- Lineage Cell Therapeutics, Inc. amortization of deferred charges for fiscal 2014 was -$1.00K.
- Lineage Cell Therapeutics, Inc. amortization of deferred charges for fiscal 2013 was -$915.00K.
- Lineage Cell Therapeutics, Inc. amortization of deferred charges for fiscal 2012 was -$211.06K.
| Period end | Amortization of Deferred Charges 3 month | Amortization of Deferred Charges 6 month | Amortization of Deferred Charges 6 month as first filed | Amortization of Deferred Charges 9 month | Amortization of Deferred Charges 9 month as first filed | Amortization of Deferred Charges 12 month | Amortization of Deferred Charges 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-09-30 | $166.00K 10-Q · filed 2018-11-08 | ||||||
| 2015-12-31 | $102.00K 10-K · filed 2016-03-15 | ||||||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-08 | -$720.00 derived: sum of 2 quarters · filed 2016-03-15 | -$720.00 derived: sum of 3 quarters · filed 2016-03-15 | -$720.00 derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-12-31 | -$720.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$720.00 derived: sum of 2 quarters · filed 2016-03-15 | -$720.00 derived: sum of 3 quarters · filed 2016-03-15 | -$1.00K 10-K · filed 2016-03-15 | -$579.00 10-K · filed 2015-03-11 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | -$280.00 10-Q · filed 2014-11-07 | -$790.40K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$280.00 10-Q · filed 2014-08-11 | -$790.40K derived: sum of 3 quarters · filed 2016-03-15 | -$839.37K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-03-31 | -$280.00 10-Q · filed 2015-05-08 | -$790.40K derived: sum of 2 quarters · filed 2016-03-15 | -$839.37K derived: sum of 3 quarters · filed 2016-03-15 | -$872.28K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2013-12-31 | -$790.12K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$839.09K derived: sum of 2 quarters · filed 2016-03-15 | -$872.00K derived: sum of 3 quarters · filed 2016-03-15 | -$915.00K 10-K · filed 2016-03-15 | -$915.03K 10-K · filed 2014-03-17 | ||
| 2013-09-30 | -$48.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$81.89K derived: sum of 2 quarters · filed 2014-11-07 | -$124.88K 10-Q · filed 2014-11-07 | -$223.24K derived: sum of 4 quarters · filed 2015-03-11 | |||
| 2013-06-30 | -$32.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$75.91K 10-Q · filed 2014-08-11 | -$174.27K derived: sum of 3 quarters · filed 2015-03-11 | -$211.18K derived: sum of 4 quarters · filed 2015-03-11 | |||
| 2013-03-31 | -$43.00K 10-Q · filed 2014-05-12 | -$141.35K derived: sum of 2 quarters · filed 2015-03-11 | -$178.26K derived: sum of 3 quarters · filed 2015-03-11 | -$215.37K derived: sum of 4 quarters · filed 2015-03-11 | |||
| 2012-12-31 | -$98.36K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | -$135.27K derived: sum of 2 quarters · filed 2015-03-11 | -$172.37K derived: sum of 3 quarters · filed 2015-03-11 | -$211.06K 10-K · filed 2015-03-11 | |||
| 2012-09-30 | -$36.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$74.02K derived: sum of 2 quarters · filed 2013-11-12 | -$112.71K 10-Q · filed 2013-11-12 | -$220.76K 10-Q · filed 2012-11-09 | -$161.45K derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-06-30 | -$37.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$75.80K 10-Q · filed 2013-08-09 | -$62.78K 10-Q · filed 2012-08-09 | -$124.54K derived: sum of 3 quarters · filed 2014-03-17 | -$208.45K derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-03-31 | -$38.69K 10-Q · filed 2013-05-10 | -$87.44K derived: sum of 2 quarters · filed 2014-03-17 | -$171.34K derived: sum of 3 quarters · filed 2014-03-17 | ||||
| 2011-12-31 | -$48.75K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$132.65K derived: sum of 2 quarters · filed 2014-03-17 | -$234.78K 10-K · filed 2014-03-17 | ||||
| 2011-09-30 | -$83.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$186.03K 10-Q · filed 2012-11-09 | |||||
| 2011-06-30 | -$102.13K 10-Q · filed 2012-08-09 | ||||||
| 2010-12-31 | -$292.90K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |